A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica

BJU International

Volumn 103, Issue 11, 2009, Pages 1482-1486

  Coard, Kathleen C M ^a   Skeete, Desiree H A ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Hospital based population; Jamaica; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLINICAL FEATURE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAMAICA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; HUMANS; JAMAICA; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 65549153615     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08265.x     Document Type: Article

References (28)

1. Gibson TN, Blake G, Hanchard B, Waugh N, McNaughton D. Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 1998-2002. West Indian Med J 2008 57 : 81 9
2. Blake G, Hanchard B, Mitchell K et al. Jamaica cancer mortality statistics, 1999. West Indian Med J 2002 51 : 64 7
3. Coard KCM. Prostate cancer at the University Hospital in Jamaica. A clinico-pathologic profile of consecutive cases at the time of needle biopsy diagnosis. West Indian Med J 2002 51 : 40 3 (Pubitemid 34567702)
4. Shirley SE, Escoffery CT, Sargeant LA, Tulloch T. Clinicopathological features of prostate cancer in Jamaican men. BJU Int 2002 89 : 390 5 (Pubitemid 34304364)
5. Gronberg H. Prostate cancer epidemiology. Lancet 2003 361 : 859 64 (Pubitemid 36331852)
6. Glover FE Coffey DS, Douglas LL et al. The epidemiology of prostate cancer in Jamaica. J Urol 1998 159 : 1984 6 (Pubitemid 29190740)
7. Brooks SEH, Hanchard B, Wolff C, Samuels E, Allen J. Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 1988-92. West Indian Med J 1995 44 : 102 5
8. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000 85 : 60 7
9. Ben-Shlomo Y, Evans S, Ibrahim F et al. The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol 2008 53 : 99 105 (Pubitemid 350166704)
10. Hankey BF, Feuer EJ, Clegg LX et al. Cancer surveillance series: interpreting trends in prostate cancer - part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999 91 : 1017 24 (Pubitemid 29293040)
11. Stephenson RA. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality and clinical factors from the SEER database. Urol Clin North Am 2002 29 : 173 81 (Pubitemid 34733112)
12. Coard K, Bishop K, Julius J. Trends in prostate pathology at the University Hospital of the West Indies, Jamaica, over the last 10 years. West Indian Med J 2002 51 : 277 8 (Pubitemid 36181950)
13. Aprikian AG, Zhang ZF, Fair WR. Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients. Cancer 1994 74 : 1768 77 (Pubitemid 24301832)
14. Bunker CH, Patrick AL, Konety BR et al. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev 2002 11 : 726 9
15. Farkas A, Schneider D, Perrotti M, Cummings KB, Ward WS. National trends in the epidemiology of prostate cancer, 1973-94: evidence for the effectiveness of prostate-specific antigen screening. Urology 1998 52 : 444 8 (Pubitemid 28399912)
16. Rietbergen JB, Hoedemaeker RF, Kruger AE, Kirkels WJ, Schroder FH. The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. J Urol 1999 161 : 1192 8 (Pubitemid 29426116)
17. Ravery V, Javerliat I, Toublanc M, Boccon-Gibod L, Delmas V, Boccon-Gibod L. Features of prostatic cancer in French individuals of African-Caribbean origin. Prog Urol 2000 10 : 231 6
18. Hoffman RM, Gilliland FD, Eley JW et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2001 93 : 388 95
19. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997 277 : 1445 51 (Pubitemid 27208886)
20. Sebo TJ, Cheville JC, Riehle DL et al. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 2001 91 : 2196 204 (Pubitemid 32476386)
21. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995 154 : 407 13
22. Aihara M, Lebovitz RM, Wheeler TM, Kinner BM, Ohori M, Scardino PT. Prostate specific antigen and Gleason grade: an immunohistochemical study of prostate cancer. J Urol 1994 151 : 1558 64 (Pubitemid 24151302)
23. Partin AW, Carter HB, Chan DW et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990 143 : 747 52 (Pubitemid 20112095)
24. Freeman VL, Leszczak J, Cooper RS. Race and the histologic grade of prostate cancer. Prostate 1997 30 : 79 84 (Pubitemid 27088115)
25. Fowler JE Bigler SA. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma. Cancer 1999 86 : 836 41 (Pubitemid 29399924)
26. Draisma G, Postma R, Schröder FH, van der Kwast TH, de Koning HJ. Gleason score, age and screening: modeling dedifferentiation in prostate cancer. Int J Cancer 2006 119 : 2366 71 (Pubitemid 44546957)
27. Epstein JI, Allsbrook WC Amin MB, Egevad LL. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol 2006 13 : 57 9 (Pubitemid 44357147)
28. Epstein JI. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am J Surg Pathol 2000 24 : 477 8 (Pubitemid 30180740)